ステムセル研究所の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/01/23 | 2,740 | 2,749 | 2,670 | 2,700 | -39 | -1.4% | 14,100 |
| 2023/01/20 | 2,788 | 2,858 | 2,679 | 2,739 | -6 | -0.2% | 29,100 |
| 2023/01/19 | 2,572 | 2,745 | 2,572 | 2,745 | +151 | +5.8% | 21,800 |
| 2023/01/18 | 2,534 | 2,594 | 2,520 | 2,594 | +62 | +2.4% | 11,000 |
| 2023/01/17 | 2,522 | 2,538 | 2,509 | 2,532 | +32 | +1.3% | 4,100 |
| 2023/01/16 | 2,538 | 2,538 | 2,481 | 2,500 | -15 | -0.6% | 5,800 |
| 2023/01/13 | 2,548 | 2,548 | 2,490 | 2,515 | -33 | -1.3% | 3,300 |
| 2023/01/12 | 2,517 | 2,569 | 2,501 | 2,548 | +8 | +0.3% | 3,500 |
| 2023/01/11 | 2,583 | 2,583 | 2,533 | 2,540 | -43 | -1.7% | 2,900 |
| 2023/01/10 | 2,600 | 2,626 | 2,526 | 2,583 | -17 | -0.7% | 4,700 |
| 2023/01/06 | 2,638 | 2,638 | 2,596 | 2,600 | -38 | -1.4% | 5,000 |
| 2023/01/05 | 2,574 | 2,640 | 2,511 | 2,638 | +61 | +2.4% | 6,300 |
| 2023/01/04 | 2,548 | 2,649 | 2,548 | 2,577 | -21 | -0.8% | 7,700 |
| 2022/12/30 | 2,500 | 2,602 | 2,500 | 2,598 | +107 | +4.3% | 5,600 |
| 2022/12/29 | 2,497 | 2,655 | 2,471 | 2,491 | -2,679 | -51.8% | 11,000 |
| 2022/12/28 | 5,030 | 5,170 | 5,030 | 5,170 | +90 | +1.8% | 6,700 |
| 2022/12/27 | 5,040 | 5,140 | 5,040 | 5,080 | -20 | -0.4% | 2,400 |
| 2022/12/26 | 5,000 | 5,100 | 5,000 | 5,100 | +60 | +1.2% | 3,300 |
| 2022/12/23 | 5,100 | 5,100 | 4,995 | 5,040 | ±0 | ±0% | 2,500 |
| 2022/12/22 | 5,000 | 5,090 | 4,990 | 5,040 | +80 | +1.6% | 1,000 |
| 2022/12/21 | 5,120 | 5,120 | 4,880 | 4,960 | +10 | +0.2% | 2,400 |
| 2022/12/20 | 4,985 | 5,080 | 4,910 | 4,950 | -15 | -0.3% | 4,000 |
| 2022/12/19 | 4,920 | 5,290 | 4,920 | 4,965 | +45 | +0.9% | 5,300 |
| 2022/12/16 | 4,910 | 4,920 | 4,870 | 4,920 | -30 | -0.6% | 2,700 |
| 2022/12/15 | 4,950 | 4,980 | 4,905 | 4,950 | -30 | -0.6% | 3,900 |
| 2022/12/14 | 4,985 | 5,030 | 4,950 | 4,980 | +15 | +0.3% | 3,000 |
| 2022/12/13 | 5,070 | 5,070 | 4,960 | 4,965 | -55 | -1.1% | 2,600 |
| 2022/12/12 | 5,030 | 5,050 | 5,020 | 5,020 | -10 | -0.2% | 1,000 |
| 2022/12/09 | 5,120 | 5,120 | 4,980 | 5,030 | +40 | +0.8% | 4,300 |
| 2022/12/08 | 5,080 | 5,090 | 4,990 | 4,990 | -10 | -0.2% | 1,500 |
| 2022/12/07 | 5,130 | 5,130 | 4,995 | 5,000 | -30 | -0.6% | 1,500 |
| 2022/12/06 | 5,070 | 5,140 | 4,960 | 5,030 | -80 | -1.6% | 3,900 |
| 2022/12/05 | 5,290 | 5,300 | 5,090 | 5,110 | -270 | -5% | 5,800 |
| 2022/12/02 | 5,300 | 5,390 | 5,280 | 5,380 | +60 | +1.1% | 1,600 |
| 2022/12/01 | 5,380 | 5,440 | 5,300 | 5,320 | +10 | +0.2% | 2,300 |
| 2022/11/30 | 5,350 | 5,380 | 5,290 | 5,310 | +60 | +1.1% | 1,800 |
| 2022/11/29 | 5,320 | 5,320 | 5,250 | 5,250 | ±0 | ±0% | 1,700 |
| 2022/11/28 | 5,270 | 5,370 | 5,250 | 5,250 | -60 | -1.1% | 2,100 |
| 2022/11/25 | 5,460 | 5,470 | 5,310 | 5,310 | -100 | -1.8% | 4,000 |
| 2022/11/24 | 5,400 | 5,490 | 5,400 | 5,410 | +10 | +0.2% | 1,400 |
| 2022/11/22 | 5,580 | 5,580 | 5,390 | 5,400 | -150 | -2.7% | 2,700 |
| 2022/11/21 | 5,400 | 5,560 | 5,360 | 5,550 | +160 | +3% | 5,000 |
| 2022/11/18 | 5,670 | 5,670 | 5,350 | 5,390 | -330 | -5.8% | 12,500 |
| 2022/11/17 | 5,790 | 5,790 | 5,650 | 5,720 | -80 | -1.4% | 13,800 |
| 2022/11/16 | 5,550 | 5,800 | 5,550 | 5,800 | +290 | +5.3% | 12,300 |
| 2022/11/15 | 5,580 | 5,580 | 5,490 | 5,510 | -70 | -1.3% | 4,100 |
| 2022/11/14 | 5,300 | 5,590 | 5,220 | 5,580 | +360 | +6.9% | 16,000 |
| 2022/11/11 | 5,290 | 5,380 | 5,220 | 5,220 | +20 | +0.4% | 8,800 |
| 2022/11/10 | 5,050 | 5,310 | 5,050 | 5,200 | +190 | +3.8% | 10,700 |
| 2022/11/09 | 5,410 | 5,590 | 5,010 | 5,010 | +120 | +2.5% | 56,900 |
651～
700
件表示中 / 1035件
類似銘柄と比較する
現在ご覧いただいている「ステムセル研」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ステムセル研 | - | +12.0% | +5.1% | - | - | - |
|
臍帯血の処理・保管の細胞バンク事業で国内民間市場ほぼ独占。臍帯保管や新規事業に展開図る |
| Ｓｃｈｏｏ | - | +17.9% | +171.3% | - | - | - |
|
法人向けオンライン研修が柱。ビジネス・デジタルスキル軸に８０００本超のコンテンツ内製 |
| ビケンテクノ | - | +3.8% | +3.4% | - | - | - |
|
清掃、警備、設備管理などの総合ビルメンテ、衛生管理業務を展開。病院買収で介護ビジネスも |
| ＡＲＭ | - | +16.0% | +11.4% | - | - | - |
|
ストレスチェックと関連ビジネスで首位級。団体長期障害所得補償保険（ＧＬＴＤ）も販売 |
| ＦＣＨＤ | - | - | - | - | - | - |
|
道路、橋梁、鉄道の調査、設計コンサルタントが中心。交通調査・自治体都市計画など官需に強い |
市場注目の銘柄
チャート関連のコラム
